Phosphate diabetes

Common Name(s)

Phosphate diabetes

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Phosphate diabetes" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Phosphate diabetes" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Phosphate diabetes" returned 27 free, full-text research articles on human participants. First 3 results:

Biochemical changes correlated with blood thiamine and its phosphate esters levels in patients with diabetes type 1 (DMT1).
 

Author(s): Nasser M Al-Daghri, Mohammed Alharbi, Kaiser Wani, Sherif H Abd-Alrahman, Eman Sheshah, Majed S Alokail

Journal:

 

Thiamine (vitamin B1) is an essential enzyme cofactor in most organisms required at several stages of anabolic and catabolic intermediary metabolism. However, little is known on the positive effects of thiamine in diabetic type 1 (DMT1) patients. The objectives of this study were ...

Last Updated: 1 Jan 2016

Go To URL
Hyperglycaemia per se does not affect erythrocyte glucose-6-phosphate dehydrogenase activity in ketosis-prone diabetes.
 

Author(s): S P Choukem, E Sobngwi, J P Garnier, S Letellier, F Mauvais-Jarvis, F Calvo, J-F Gautier

Journal: Diabetes Metab.. 2015 Sep;41(4):326-30.

 

Previously, we described patients with ketosis-prone type 2 diabetes (KPD) and glucose-6-phosphate dehydrogenase (G6PD) deficiency, but no mutation of the G6PD gene. Our present study used two complementary approaches to test whether hyperglycaemia might inhibit G6PD activity: (1) ...

Last Updated: 19 Sep 2015

Go To URL
High frequency of diabetes and impaired fasting glucose in patients with glucose-6-phosphate dehydrogenase deficiency in the Western brazilian Amazon.
 

Author(s): Marli S Santana, Wuelton M Monteiro, Mônica R F Costa, Vanderson S Sampaio, Marcelo A M Brito, Marcus V G Lacerda, Maria G C Alecrim

Journal: Am. J. Trop. Med. Hyg.. 2014 Jul;91(1):74-6.

 

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is one of the most common human genetic abnormalities, and it has a significant prevalence in the male population (X chromosome linked). The purpose of this study was to estimate the frequency of impaired fasting glucose and diabetes ...

Last Updated: 3 Jul 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Phosphate diabetes" returned 1 free, full-text review articles on human participants. First 3 results:

Review of sitagliptin phosphate: a novel treatment for type 2 diabetes.
 

Author(s): Baptist Gallwitz

Journal: Vasc Health Risk Manag. 2007 ;3(2):203-10.

 

Sitagliptin (Januvia, Merck Pharmaceuticals) is a dipeptidyl-peptidase inhibitor (DPP-4 inhibitor) that has recently been approved for the therapy of type 2 diabetes. Like other DPP-4 inhibitors its action is mediated by increasing levels of the incretin hormones glucagon-like peptide-1 ...

Last Updated: 21 Jun 2007

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy Volunteers
 

Status: Recruiting

Condition Summary: Diabetes; PTH; Vitamin D; Fibroblast Growth Factor (FGF23); Phosphate

 

Last Updated: 9 Nov 2016

Go to URL
Treatment of Diabetes in Patients With Systolic Heart Failure
 

Status: Recruiting

Condition Summary: Heart Failure, Systolic; Diabetes Mellitus, Type 2

 

Last Updated: 10 Nov 2016

Go to URL